Formidable Asset Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Formidable Asset Management’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-862	Closed	-$5K	–	484
2016 Q1	$5K	Hold	862	–	–	﹤0.01%	414
2015 Q4	$7K	Hold	862	–	–	﹤0.01%	433
2015 Q3	$10K	Hold	862	–	–	0.01%	417
2015 Q2	$8K	Hold	862	–	–	0.01%	398
2015 Q1	$6K	Hold	862	–	–	﹤0.01%	419
2014 Q4	$5K	Hold	862	–	–	﹤0.01%	407
2014 Q3	$5K	Hold	862	–	–	﹤0.01%	406
2014 Q2	$6K	Hold	862	–	–	﹤0.01%	421
2014 Q1	$6K	Hold	862	–	–	﹤0.01%	378
2013 Q4	$6K	Hold	862	–	–	﹤0.01%	399
2013 Q3	$6K	Buy	+862	New	+$5.8K	0.01%	351

Other funds holding JNP

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

CCM

Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Formidable Asset Management's JNP Position: Q2 2016 in Review

Formidable Asset Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q2 2016, closing a stake of 862 shares — an estimated $5K sold.

Formidable Asset Management first reported a position in JNP in Q3 2013 and held it in 11 quarters. The position peaked at $10K in Q3 2015. 51 funds tracked by Wall St. Rank hold JNP as of Q2 2016.

Formidable Asset Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Formidable Asset Management sold 862 Juniper Pharmaceuticals, Inc. Common Stock shares in Q2 2016, an estimated $5K.
Formidable Asset Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 11 quarters.
Formidable Asset Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $10K in Q3 2015.
51 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q2 2016.

Based on Formidable Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.